AUROBINDO PHARMA LTD. - Completion Of US FDA Inspection At Our Unit VI - B
Download 
|
< Back |
| 30 Sep 2023 | |
| The US FDA inspected the Company''s Unit VI-B, a formulation facility from September 22 to September 29, 2023 and at the end of the inspection a Form 483 was issued with one observation which is procedural in nature. | |
| View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback